Journal issues > Issue 1, January 2020 > The 13^th Belgian symposium on the integration of molecular biology advances into oncology clinical practice (BSMO/Bordet meeting)

The 13^th Belgian symposium on the integration of molecular biology advances into oncology clinical practice (BSMO/Bordet meeting)

By: J. Blokken PhD, PharmD, Tom Feys MBA, MSc

SUMMARY

On the 22^nd and 23^rd of November 2019, the Jules Bordet Institute and the Belgian Society of Medical Oncology (BSMO) hosted the 13^th Belgian symposium on the integration of molecular biology advances into oncology clinical practice. In the course of the symposium, a fine selection of Belgian and international key opinion leaders discussed the clinical impact of molecular biology advances in a plethora of cancer types.

(BELG J MED ONCOL 2020;14(1):31–41)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)